Based on these results together with their known inhibitory effects on cancer cell proliferation and metastasis41,42, combined treatment with both PLK1 and PTP4A1 inhibitors could be an effective therapy for metastatic breast cancer. The gene discussed is PLK1; the disease is cancer.